Full text is available at the source.
Astrocytic adrenergic α2 receptor contributes to the mechanisms underlying the circadian rhythmicity of seizure susceptibility
Brain support cells’ alpha-2 receptors may help control daily changes in seizure risk
AI simplified
Abstract
Clozapine N-oxide (CNO) at a dose of 0.5 mg/kg elicited significantly more severe seizures during the light phase compared with the dark phase.
- Circadian patterns in seizure susceptibility have been observed in patients with epilepsy.
- Chemogenetic activation of the Gi pathway in hippocampal astrocytes reduced mild seizure occurrences specifically during the light phase.
- Knockdown of adrenergic α2 receptors in astrocytes increased seizure susceptibility during the light phase, while administration of an α2 agonist partially reversed this effect.
- Atipamezole, an α2 antagonist, enhanced lactate production in astrocytes, indicating a potential link between adrenergic signaling and metabolic responses.
- Supplementing with medium-chain fatty acids in epileptic mice mitigated seizure exacerbation caused by α2 receptor knockdown, likely due to the production of ketone bodies.
AI simplified